|
|
| | 6-AZAURIDINE 2',3',5'-TRIACETATE Basic information |
| Product Name: | 6-AZAURIDINE 2',3',5'-TRIACETATE | | Synonyms: | 2μ,3μ,5μ-Tri-O-acetyl-6-azauridine, 6-Azauridine 2μ,3μ,5μ-triacetate, 6-AzUrd-TA, Azaribine, 2-β-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione 2μ,3μ,5μ-triacetate;6-Azauridine 2μ,3μ,5μ-triacetate, 6-AzUrd-TA, Azaribine;2-(2-O,3-O,5-O-Triacetyl-β-D-ribofuranosyl)-1,2,4-triazine-3,5(2H,4H)-dione;6-Azauridine 2',3',5'-triacetate,98%;2-(2’,3’,5’-triacetyl-beta-d-ribofuranosyl)-as-triazine-3,5-(2h,4h)-dione;2’,3’,5’-triacetyl-6-azauridine;4h)-dione,2-(2’,3’,5’-triacetyl-beta-d-ribofuranosyl)-as-triazine-5-(2h;cb304 | | CAS: | 2169-64-4 | | MF: | C14H17N3O9 | | MW: | 371.3 | | EINECS: | 218-515-6 | | Product Categories: | | | Mol File: | 2169-64-4.mol |  |
| | 6-AZAURIDINE 2',3',5'-TRIACETATE Chemical Properties |
| Melting point | 99-101 °C(lit.) | | Boiling point | 501.01°C (rough estimate) | | density | 1.3535 (rough estimate) | | refractive index | 1.5700 (estimate) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | color | White to Light Yellow | | Stability: | Hygroscopic |
| Safety Statements | 22-24/25 | | WGK Germany | 2 | | RTECS | XY8577000 |
| | 6-AZAURIDINE 2',3',5'-TRIACETATE Usage And Synthesis |
| Chemical Properties | white to off-white powder or crystals | | Uses | Antipsoriatic. | | Definition | ChEBI: A N-glycosyl-1,2,4-triazine that is 6-azauridine acetylated at positions 2', 3' and 5' on the sugar ring. It is a prodrug for 6-azauridine and is used for treatment of psoriasis. | | Brand name | Triazure (Parke-Davis);Cb 304;Ribo-azauracil. | | World Health Organization (WHO) | Azaribine, an antineoplastic agent, was introduced in 1975 for the
treatment of severe, recalcitrant, disabling arthritis. Following reports of
thromboembolic and thrombotic reactions, the drug was withdrawn in the USA in
1976. The causal relationship between azaribine and these events has been
questioned and the drug remains available in the USA for investigational purposes. |
| | 6-AZAURIDINE 2',3',5'-TRIACETATE Preparation Products And Raw materials |
|